{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:55:19Z","timestamp":1789563319133,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018493","name":"Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jmii.2019.05.008","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T03:08:14Z","timestamp":1560913694000},"page":"193-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enhanced uropathogenic Escherichia coli-induced infection in uroepithelial cells by sugar through TLR-4 and JAK\/STAT1 signaling pathways"],"prefix":"10.1016","volume":"54","author":[{"given":"Chen-Hsun","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Kwung","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Tien","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ching","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2019.05.008_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mda.2003.8","article-title":"The etiology of urinary tract infection: traditional and emerging pathogens","volume":"49","author":"Ronald","year":"2003","journal-title":"Dis Mon"},{"key":"10.1016\/j.jmii.2019.05.008_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/sm2.17","article-title":"Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women","volume":"1","author":"Goldstein","year":"2013","journal-title":"Sex Med"},{"key":"10.1016\/j.jmii.2019.05.008_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mcna.2010.08.023","article-title":"Urinary tract infections in women","volume":"95","author":"Dielubanza","year":"2011","journal-title":"Med Clin N Am"},{"key":"10.1016\/j.jmii.2019.05.008_bib4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","article-title":"Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy","volume":"54","author":"Naber","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmii.2019.05.008_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mpmed.2007.05.009","article-title":"Urinary tract infection","volume":"35","author":"Lee","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.jmii.2019.05.008_bib6","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/emboj\/19.12.2803","article-title":"Type 1 pilus-mediated bacterial invasion of bladder epithelial cells","volume":"19","author":"Martinez","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.jmii.2019.05.008_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0891-5520(05)70383-4","article-title":"Bacterial urinary tract infections in diabetes","volume":"11","author":"Patterson","year":"1997","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.jmii.2019.05.008_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jdiacomp.2012.06.008","article-title":"Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD)","volume":"26","author":"Hirji","year":"2012","journal-title":"J Diabet Complicat"},{"key":"10.1016\/j.jmii.2019.05.008_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5414\/CN107216","article-title":"Urinary tract infection in patients with diabetes mellitus","volume":"77","author":"Funfstuck","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jmii.2019.05.008_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jmii.2011.12.024","article-title":"Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection","volume":"46","author":"Wang","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2019.05.008_bib11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40264-014-0213-4","article-title":"Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events","volume":"37","author":"Ptaszynska","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.jmii.2019.05.008_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007165","article-title":"Cardiovascular safety, long-term noncardiovascular safety, and efficacy of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systemic review and meta-analysis with trial sequential analysis","volume":"7","author":"Zhang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jmii.2019.05.008_bib13","first-page":"129","article-title":"Emphysematous cystitis in a patient with type 2 diabetes mellitus","volume":"65","author":"Toyota","year":"2011","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jmii.2019.05.008_bib14","first-page":"393","article-title":"Clinical features and prognostic factors of emphysematous urinary tract infection","volume":"42","author":"Kuo","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2019.05.008_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/BST0390349","article-title":"Glycosylation changes as important factors for the susceptibility to urinary tract infection","volume":"39","author":"Taganna","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jmii.2019.05.008_bib16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.ajkd.2005.05.019","article-title":"Host and bacterial virulence factors predisposing to emphysematous pyelonephritis","volume":"46","author":"Tseng","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jmii.2019.05.008_bib17","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ijantimicag.2007.07.042","article-title":"Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment","volume":"31","author":"Geerlings","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2019.05.008_bib18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.52.5.1256","article-title":"High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells","volume":"52","author":"Shanmugam","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jmii.2019.05.008_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.phrs.2015.07.006","article-title":"Nrf2 activators modulate oxidative stress responses and bioenergetic profiles of human retinal epithelial cells cultured in normal or high glucose conditions","volume":"99","author":"Foresti","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jmii.2019.05.008_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/labinvest.2009.45","article-title":"PPAR[gamma] agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway","volume":"89","author":"Ji","year":"2009","journal-title":"Lab Investig"},{"key":"10.1016\/j.jmii.2019.05.008_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2007-2185","article-title":"Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state","volume":"93","author":"Devaraj","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmii.2019.05.008_bib22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc09-1799","article-title":"Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects","volume":"33","author":"Dasu","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jmii.2019.05.008_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108844","article-title":"The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose","volume":"9","author":"Mudaliar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2019.05.008_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1189\/jlb.1206763","article-title":"Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation","volume":"82","author":"Hu","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jmii.2019.05.008_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.imbio.2006.05.007","article-title":"Signal integration between IFNgamma and TLR signalling pathways in macrophages","volume":"211","author":"Schroder","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.jmii.2019.05.008_bib26","doi-asserted-by":"crossref","first-page":"650812","DOI":"10.1155\/2013\/650812","article-title":"SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in\u00a0vivo","volume":"2013","author":"Chaves de Souza","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jmii.2019.05.008_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yjmcc.2014.07.021","article-title":"NK-derived IFN-gamma\/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis","volume":"76","author":"Liu","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmii.2019.05.008_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2013.08.009","article-title":"Synergistic activation of inflammatory cytokine genes by interferon-gamma-induced chromatin remodeling and toll-like receptor signaling","volume":"39","author":"Qiao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jmii.2019.05.008_bib29","article-title":"Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK\/STAT-1 signaling pathway","volume":"12","author":"Ho","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2019.05.008_bib30","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.4049\/jimmunol.1400594","article-title":"Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-gamma signaling","volume":"193","author":"Wang","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jmii.2019.05.008_bib31","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/IAI.00323-09","article-title":"Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli","volume":"77","author":"Berry","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2019.05.008_bib32","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2337\/diacare.25.8.1405","article-title":"Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects","volume":"25","author":"Geerlings","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jmii.2019.05.008_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001042","article-title":"Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection","volume":"6","author":"Hannan","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jmii.2019.05.008_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MBP-0015-2014","article-title":"Sialic acid and N-acetylglucosamine regulate type 1 fimbriae synthesis","volume":"3","author":"Blomfield","year":"2015","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jmii.2019.05.008_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftu004","article-title":"Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice","volume":"73","author":"Ozer","year":"2015","journal-title":"Pathog Dis"},{"key":"10.1016\/j.jmii.2019.05.008_bib36","first-page":"459","article-title":"Signal diversity of receptor for advanced glycation end products","volume":"71","author":"Sakaguchi","year":"2017","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jmii.2019.05.008_bib37","doi-asserted-by":"crossref","first-page":"e00104","DOI":"10.1128\/mBio.00104-16","article-title":"Metabolic requirements of Escherichia coli in intracellular bacterial communities during urinary tract infection pathogenesis","volume":"7","author":"Conover","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.jmii.2019.05.008_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14715\/cmb\/2018.64.13.4","article-title":"Expression of toll-like receptor 4 and its connection with type 2 diabetes mellitus","volume":"64","author":"Taha","year":"2018","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.jmii.2019.05.008_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-065X.2008.00707.x","article-title":"Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms","volume":"226","author":"Hu","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jmii.2019.05.008_bib40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jmii.2019.05.008_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4161\/jkst.22469","article-title":"STAT1 as a central mediator of IFNgamma and TLR4 signal integration in vascular dysfunction","volume":"1","author":"Sikorski","year":"2012","journal-title":"Jak-Stat"},{"key":"10.1016\/j.jmii.2019.05.008_bib42","doi-asserted-by":"crossref","first-page":"C1337","DOI":"10.1152\/ajpcell.00276.2010","article-title":"STAT1-mediated signal integration between IFNgamma and LPS leads to increased EC and SMC activation and monocyte adhesion","volume":"300","author":"Sikorski","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jmii.2019.05.008_bib43","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.4049\/jimmunol.172.10.6345","article-title":"Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling","volume":"172","author":"Rothfuchs","year":"2004","journal-title":"J Immunol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118218303062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118218303062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:25:42Z","timestamp":1761657942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118218303062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1684118218303062"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2019.05.008","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced uropathogenic Escherichia coli-induced infection in uroepithelial cells by sugar through TLR-4 and JAK\/STAT1 signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2019.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}